Cancer stem cells (CSCs) represent an extremely small subpopulation of tumor cells and are characterized by the ability to self-renew and differentiate. This special group of tumor cells has a slower growth rate relative to other tumor cells, endowing CSCs with high resistance to traditional chemo and radiation therapies that target rapidly dividing cells (1)…. Read article →
Dr. Joby Chesnick is a Senior Global Marketing Manager in Demand Generation at QIAGEN. She received her Ph.D. in Biology, with doctoral research specializing in unicellular algal symbioses at Texas A&M University. Afterwards, she was awarded an NSF Post-Doctoral Fellowship in Plant Biology and investigated organelle acquisition by primitive eukaryotes at the University of Washington in Seattle. In 2007, Joby additionally received her M.B.A. from the University of Wisconsin-Madison. Her work experience spans 18 years in the biotech industry, and includes positions in bioinformatics support, technical support, intellectual property, product management, and sales prior to joining QIAGEN in January 2017.